ALPHA MEDICALS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ALPHA MEDICALS
Largest movements
- Receivables within one year -€108,190
down €108,190 (-87.7%), from €123,430 to €15,240
of which Trade receivables: -€123,430
- Cash -€14,351
down €14,351 (-100.0%), from €14,356 to €4
mainly Other debts (-€115,531) and Debts after one year (-€44,637)
- Other debts -€115,531
down €115,531 (-18.2%), from €633,876 to €518,346
- Profit (loss) carried forward +€50,323
up €50,323 (+23.2%), from €216,562 to €266,884
- Debts after one year -€44,637
down €44,637 (-56.7%), from €78,657 to €34,020
- Gross operating margin -€97,619
down €97,619 (-52.2%), from €187,013 to €89,394
- Taxes -€26,458
down €26,458 (-66.1%), from €40,028 to €13,570
- Financial charges -€13,483
down €13,483 (-35.3%), from €38,172 to €24,690
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,057,617 | €941,246 | -€116,371 | -11.0% |
| Fixed assets | 21/28 | €919,832 | €925,725 | +€5,893 | +0.6% |
| Tangible fixed assets | 22/27 | €425,984 | €431,876 | +€5,893 | +1.4% |
| Land and buildings | 22 | €321,440 | €321,440 | = | 0.0% |
| Furniture and vehicles | 24 | - | €5,893 | +€5,893 | |
| Assets under construction and advance payments | 27 | €104,544 | €104,544 | = | 0.0% |
| Financial fixed assets | 28 | €493,848 | €493,848 | = | 0.0% |
| Current assets | 29/58 | €137,786 | €15,522 | -€122,264 | -88.7% |
| Amounts receivable within one year | 40/41 | €123,430 | €15,240 | -€108,190 | -87.7% |
| Trade receivables | 40 | €123,430 | - | -€123,430 | |
| Other amounts receivable | 41 | - | €15,240 | +€15,240 | |
| Cash at bank and in hand | 54/58 | €14,356 | €4 | -€14,351 | -100.0% |
| Deferred charges and accrued income | 490/1 | - | €277 | +€277 | |
| Total equity and liabilities | 10/49 | €1,057,617 | €941,246 | -€116,371 | -11.0% |
| Equity | 10/15 | €236,562 | €286,884 | +€50,323 | +21.3% |
| Contributions | 10/11 | €20,000 | €20,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €216,562 | €266,884 | +€50,323 | +23.2% |
| Amounts payable | 17/49 | €821,056 | €654,362 | -€166,694 | -20.3% |
| Amounts payable after more than one year | 17 | €78,657 | €34,020 | -€44,637 | -56.7% |
| Financial debts | 170/4 | €78,657 | €34,020 | -€44,637 | -56.7% |
| Amounts payable within one year | 42/48 | €733,874 | €620,211 | -€113,662 | -15.5% |
| Current portion of amounts payable after more than one year | 42 | €47,440 | €48,320 | +€880 | +1.9% |
| Trade debts | 44 | €3,312 | €6,200 | +€2,888 | +87.2% |
| Suppliers | 440/4 | €3,312 | €6,200 | +€2,888 | +87.2% |
| Taxes, remuneration and social security | 45 | €49,246 | €47,346 | -€1,900 | -3.9% |
| Taxes | 450/3 | €49,246 | €47,346 | -€1,900 | -3.9% |
| Other amounts payable | 47/48 | €633,876 | €518,346 | -€115,531 | -18.2% |
| Accrued charges and deferred income | 492/3 | €8,525 | €130 | -€8,394 | -98.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | - | €1,192 | +€1,192 | |
| Gross operating margin | 9900 | €187,013 | €89,394 | -€97,619 | -52.2% |
| Operating profit (loss) | 9901 | €187,013 | €88,202 | -€98,811 | -52.8% |
| Financial income | 75/76B | - | €380 | +€380 | |
| Recurring financial income | 75 | - | €380 | +€380 | |
| Financial charges | 65/66B | €38,172 | €24,690 | -€13,483 | -35.3% |
| Recurring financial charges | 65 | €38,172 | €24,690 | -€13,483 | -35.3% |
| Profit (loss) for the period before taxes | 9903 | €148,840 | €63,893 | -€84,948 | -57.1% |
| Income taxes | 67/77 | €40,028 | €13,570 | -€26,458 | -66.1% |
| Profit (loss) for the period | 9904 | €108,812 | €50,323 | -€58,490 | -53.8% |
| Profit (loss) for the period to be appropriated | 9905 | €108,812 | €50,323 | -€58,490 | -53.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 22 October 2026 via checked.be.